By Iain Gilbert
Date: Thursday 02 Oct 2025
(Sharecast News) - Optibiotix Health revealed on Thursday that finance director David Blain had acquired 84,053 ordinary shares in the AIM-listed life sciences business.
Holding(s) in Company | 13-Oct-2025 | 15:31 | RNS |
Director/PDMR Shareholding | 02-Oct-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 24-Sep-2025 | 12:28 | RNS |
Half-year Report | 16-Sep-2025 | 07:00 | RNS |
Admission to Trading on the OTCQB Venture Market | 21-Aug-2025 | 07:00 | RNS |
£5.7m float for weight-fighting OptiBiotix after... | 04-Aug-2014 | Express & Star |
No recent information was found.
No recent information was found.
Currency | UK Pounds |
Share Price | 9.33p |
Change Today | 0.083p |
% Change | 0.90 % |
52 Week High | 22.60 |
52 Week Low | 8.90 |
Volume | 113,989 |
Shares Issued | 103.30m |
Market Cap | £9.64m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:03 | 3,457 @ 9.08p |
09:01 | 4,192 @ 9.40p |
08:49 | 106,340 @ 9.40p |
CEO | Stephen O'Hara |
Finance Director | David Blain |
You are here: research